IPO - Jin Medical International Ltd.

Add to your watchlist
Back to List of IPO Filings

Form Type: F-3

Filing Date: 2025-06-25

Corporate Action: Ipo

Type: New

Accession Number: 000121390025057795

Filing Summary: On June 25, 2025, Jin Medical International Ltd. filed a registration statement under Form F-3 with the U.S. Securities and Exchange Commission. The registration outlines the company’s plan to offer securities including ordinary shares, warrants, debt securities, rights, and units up to an aggregate amount of $300,000,000. Jin Medical, a Cayman Islands holding company, conducts its operations through a variable interest entity in China. Under its current structure, investors do not hold direct equity interests in the Chinese operating company, Changzhou Zhongjin Medical Equipment Co. Ltd., but rather through contractual arrangements due to Chinese laws restricting foreign direct investment in domestic companies. The filing indicates that Jin Medical is classified as an emerging growth company and is subject to reduced reporting requirements. The registration seeks approval to raise capital for business expansion amidst the existing legal and operational risks tied to regulations from the Chinese government and recent changes to the accounting standards applicable to foreign companies.

Additional details:

Approximate Date Of Commencement Of Proposed Sale: From time to time after the effective date


Ordinary Shares Registered: Up to $300,000,000


Last Reported Sale Price: $0.6594


Public Float Value: $34,420,259


Number Of Outstanding Ordinary Shares: 156,547,100


Number Of Shares Held By Non Affiliates: 37,824,460


Highest Closing Sale Price Last 60 Days: $0.91


Substantial Liabilities: None reported for the past three years


Dividends: None paid and no future dividends anticipated


Regulatory Risks: Risks associated with potential restrictions or changes in Chinese law affecting the holding company structure


Auditor: Audit Alliance LLP, PCAOB-registered firm headquartered in Singapore


Comments

No comments yet. Be the first to comment!